|
|
Volumn 66, Issue 1, 2006, Pages 153-
|
|
Lamotrigine and the risk of malformations in pregnancy [3]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
LAMOTRIGINE;
TRIAZINE DERIVATIVE;
ANTICONVULSANT THERAPY;
BIRTH DEFECT;
CHROMOSOME ABERRATION;
CONGENITAL MALFORMATION;
EARLY DIAGNOSIS;
FIRST TRIMESTER PREGNANCY;
HUMAN;
LETTER;
POPULATION RISK;
PREGNANCY;
PRENATAL DRUG EXPOSURE;
PREVALENCE;
PRIORITY JOURNAL;
CROSS-SECTIONAL STUDY;
DRUG EFFECT;
EPIDEMIOLOGY;
FEMALE;
GENETIC PREDISPOSITION;
GENETICS;
NOTE;
PATHOPHYSIOLOGY;
PRENATAL EXPOSURE;
REGISTER;
REPRODUCIBILITY;
RISK ASSESSMENT;
RISK FACTOR;
STATISTICAL ANALYSIS;
ABNORMALITIES, DRUG-INDUCED;
ANTICONVULSANTS;
CAUSALITY;
CROSS-SECTIONAL STUDIES;
DATA INTERPRETATION, STATISTICAL;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
PREGNANCY;
PREGNANCY TRIMESTER, FIRST;
PRENATAL EXPOSURE DELAYED EFFECTS;
REGISTRIES;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
RISK FACTORS;
TRIAZINES;
|
|
EID: 33645825231
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000203710.88804.29 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
